New patch aims to stop bleeding faster in keyhole surgery
NCT ID NCT05900037
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tested a new device called GATT-Patch, a flexible, resorbable patch that helps stop bleeding during minimally invasive (keyhole) liver and gallbladder surgeries. 53 adults were randomly assigned to receive either GATT-Patch or a standard surgical patch. The main goal was to see if GATT-Patch could stop bleeding within 7 minutes without rebleeding. The study is complete, but results are not yet available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GATT-Patch (a resorbable sealing patch made from porcine gelatin and a polymer coating)
What this could lead to
If it works, this could give surgeons a better tool to quickly stop bleeding during keyhole liver and gallbladder surgeries.
What could go wrong
This is a small, early-stage trial with only 53 participants, so results may not apply to everyone. The patch may not work better than existing options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAOPERATIVE BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrium Health
Charlotte, North Carolina, 28204, United States
-
Capital Health
Pennington, New Jersey, 08534, United States
-
Intermountain Healthcare
Murray, Utah, 84111, United States
-
University of Southern California
Los Angeles, California, 90033, United States
-
Washington University
St Louis, Missouri, 63110, United States
-
Weill-Cornell
New York, New York, 10065, United States